Clinical Trial Update: Comparative Effectiveness of Tirzepatide and Semaglutide in Individuals at Cardiovascular Risk

View source ↗

Summary

This completed trial compares tirzepatide and semaglutide for cardiovascular risk in adults with type 2 diabetes and overweight. The study population includes i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease Risk
• Overweight
• Type 2 Diabetes Mellitus

Drugs mentioned

• Tirzepatide (tirzepatide)
• semaglutide (semaglutide)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Type 2 Diabetes, Overweight | Status: COMPLETED